期刊文献+

504株铜绿假单胞菌分布及耐药性分析 被引量:1

Distribution and the drug resistance of 504 pseudomonas aeruginosa isolates
下载PDF
导出
摘要 目的:调查山西大医院铜绿假单胞菌的分布特点,并分析其在不同感染部位、不同临床科室之间耐药性的差异。方法:收集分离的铜绿假单胞菌504株,采用K-B法对菌株进行药敏试验,通过WHONET5.6软件对药敏结果进行统计分析。结果:分离得到铜绿假单胞菌主要来源于下呼吸道标本(75.2%),临床感染科室主要以ICU、神经内科、呼吸科、神经外科为主。不同感染部位、不同临床科室分离菌株对同种抗菌药物的耐药率比较差异有统计学意义(P<0.05)。结论:山西大医院呼吸科、ICU、神经内科和神经外科仍然是院内感染控制的重点科室。应加强对头孢哌酮/舒巴坦和亚胺培南的管理及耐药性监测,控制耐药趋势。 Objective:To investigate the distribution and the drug resistance of the P.aeruginosa which isolated from different sites of infection and different clinical department.Methods:Collect 504 P.aeruginosa isolates from the hospitalized patients,the antibiotic suscepitibility testing was performed with K-B method then the results were statistically analyzed by the software WHONET 5.6.Results:The P.aeruginosa strains were mainly isolated from the lower respiratory specimen(75.2%),most of them were obtained from the patients of ICU,neurology department,respiratory medicine department and neurosurgery department.Cefoperazone/sulbactam and imipenem performed a higher drug resistance.The differences of the drug resistance of P.aeruginosa strains which isolated from different sites of infection and different clinical departments were statistically siginificance(P〈0.05).Conclution:The key departments for the hospital infection control still were ICU,neurology department,respiratory medicine department and neurosurgery department.It is necessary to enhance the management of the use of cefoperazone/sulbactam and imipenem as well as to monitor the drug resistance of the P.aeruginosa strains so as to reduce the growing of the drug-resistance strains.
机构地区 山西大医院
出处 《临床医药实践》 2017年第1期42-45,共4页 Proceeding of Clinical Medicine
关键词 铜绿假单胞菌 临床分布 耐药性 paeruginosa distribution of clinic drug resistance
  • 相关文献

参考文献7

二级参考文献70

  • 1许宏涛,陈东科,俞云松,张秀珍.多重耐药铜绿假单胞菌产β-内酰胺酶耐药机制研究[J].中华医院感染学杂志,2005,15(1):20-22. 被引量:81
  • 2官兰,宋诗铎,胡文芝,祁伟,魏殿军.临床分离多重耐药假单胞菌耐药机制的研究[J].中华传染病杂志,1996,14(1):32-35. 被引量:20
  • 3孙南雄,童明庆,潘世杨.感染性疾病实验诊断[M].南京:台海出版社,2002:211-215.
  • 4Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux[J]. Science, 1994, 264: 382-388.
  • 5Ochs MM, McCusker MP, Bains M, et al. Negative regulation of Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acid [J]. Antimierob Agents Chemother, 1999,43 : 1085-1090.
  • 6Bush K, Jacoby GA, Medeiros AA. A functional classifica tion scheme for β-lactamases and aminoglycosidc enzymes[J]. Curr Opin Microbiol, 1998,1 : 509.
  • 7Piddock PLLJ. Two efflux system expressed simultaneoudly in multidrug-resistant Pseudomonas aeruginosa [J]. Antimicrob Agents Chemother, 2000,44:2861.
  • 8Maseda H, Yoneyama H, Nakae TJ. Assignment of the substrate-selective subunits of the Mex-OprN multidrug efflux pump of Pseudornonas aeruginosa [J]. Antimicrob Agents Chemother, 2000,44.. 658.
  • 9Dautrey C, Vissuzaine C, Carbon, etal. Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats[J]. Antimicrob Agents Chemother, 2001, 45:571.
  • 10Okamoto K, Gotoh N, Nishino T. Extrusion of penem antibi otics by multicomponent efflux sustems MexAB OprM, Mex CD-OprJ, and MexXY-OprM of Pseudomonasaeruginosa[J] Antimierob Agents Chemother, 2002,46: 2696.

共引文献119

同被引文献14

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部